Item 1. Financial Statements
Item 1. Financial Statements (unaudited)
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED BALANCE SHEET S
(Unaudited)
September 30,
March 31,
2023
2023
(In thousands, except share
and per share amounts)
ASSETS
Cash and cash equivalents
$
24,669
$
27,212
Short-term investments
651
3,363
Accounts receivable, net
3,084
3,471
Inventories
5,577
6,415
Prepaid expenses and other current assets
1,258
1,414
Total current assets
35,239
41,875
Property and equipment, net
7,060
7,423
Operating lease right-of-use assets
1,031
684
Goodwill
7,978
7,978
Intangible assets, net
1,672
1,790
Deposits
120
126
Total assets
$
53,100
$
59,876
LIABILITIES AND STOCKHOLDERS’ EQUITY
Accounts payable ($ 0 and $ 8 to a related party)
$
864
$
1,621
Lease liabilities, current
396
413
Accrued expenses and other liabilities
5,142
5,168
Total current liabilities
6,402
7,202
Deferred tax liability
13
12
Lease liabilities, non-current
592
238
Contingent consideration, non-current
728
1,052
Total liabilities
7,735
8,504
Commitments and contingencies (Note 9)
Stockholders’ equity:
Preferred stock: $ 0.001 par value authorized: 5,000,000 shares; issued and outstanding: none
—
—
Common Stock: $ 0.001 par value authorized: 150,000,000 shares; issued and outstanding : 25,216,143 and 24,685,059 shares, respectively
25
25
Additional paid-in capital
59,075
55,953
Accumulated other comprehensive loss
( 91 )
( 127 )
Retained deficit
( 13,644 )
( 4,479 )
Total stockholders’ equity
45,365
51,372
Total liabilities and stockholders’ equity
$
53,100
$
59,876
The accompanying notes are an integral part of these condensed consolidated financial statements.
2
Table of Contents
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATION S
(Unaudited)
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands, except per share amounts)
(In thousands, except per share amounts)
Net revenues
$
5,708
$
8,953
$
11,295
$
17,862
Cost of revenues ($ 0 , $ 140 , $ 0 and $ 197 to a related party)
2,587
3,351
5,105
6,895
Gross profit
3,121
5,602
6,190
10,967
Operating expenses:
Research and development
4,691
6,395
9,895
13,014
Selling, general and administrative
2,523
2,412
5,527
5,100
Total operating expenses
7,214
8,807
15,422
18,114
Loss from operations
( 4,093 )
( 3,205 )
( 9,232 )
( 7,147 )
Interest income, net
131
55
274
77
Other expense, net
( 60 )
( 41 )
( 123 )
( 37 )
Loss before income taxes
( 4,022 )
( 3,191 )
( 9,081 )
( 7,107 )
Provision for income taxes
33
37
84
97
Net loss
$
( 4,055 )
$
( 3,228 )
$
( 9,165 )
$
( 7,204 )
Net loss per share:
Basic
$
( 0.16 )
$
( 0.13 )
$
( 0.37 )
$
( 0.29 )
Diluted
$
( 0.16 )
$
( 0.13 )
$
( 0.37 )
$
( 0.29 )
Weighted average shares used in per share calculations:
Basic
25,161
24,554
25,014
24,538
Diluted
25,161
24,554
25,014
24,538
The accompanying notes are an integral part of these condensed consolidated financial statements.
3
Table of Contents
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Unaudited)
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
Net loss
$
( 4,055 )
$
( 3,228 )
$
( 9,165 )
$
( 7,204 )
Net unrealized gain (loss) on available-for-sale investments
9
2
36
( 25 )
Total comprehensive loss
$
( 4,046 )
$
( 3,226 )
$
( 9,129 )
$
( 7,229 )
The accompanying notes are an integral part of these condensed consolidated financial statements.
4
Table of Contents
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Comprehensive
Retained
Stockholders'
Shares
Amount
Capital
Loss
Deficit
Equity
Three months ended September 30, 2023
(In thousands, except share amounts)
Balance, June 30, 2023
25,083,143
$
25
$
58,246
$
( 100 )
$
( 9,589 )
$
48,582
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs of $ 389
133,000
—
153
—
—
153
Stock-based compensation expense
—
—
676
—
—
676
Net loss
—
—
—
—
( 4,055 )
( 4,055 )
Net unrealized gain on available-for-sale investments
—
—
—
9
—
9
Balance, September 30, 2023
25,216,143
$
25
$
59,075
$
( 91 )
$
( 13,644 )
$
45,365
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Comprehensive
Retained
Stockholders'
Shares
Amount
Capital
Loss
Earnings
Equity
Three months ended September 30, 2022
(In thousands, except share amounts)
Balance, June 30, 2022
24,553,753
$
25
$
53,899
$
( 181 )
$
7,522
$
61,265
Stock-based compensation expense
—
—
661
—
—
661
Net loss
—
—
—
—
( 3,228 )
( 3,228 )
Net unrealized gain on available-for-sale investments
—
—
—
2
—
2
Balance, September 30, 2022
24,553,753
$
25
$
54,560
$
( 179 )
$
4,294
$
58,700
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Comprehensive
Retained
Stockholders'
Shares
Amount
Capital
Loss
Deficit
Equity
Six months ended September 30, 2023
(In thousands, except share amounts)
Balance, March 31, 2023
24,685,059
$
25
$
55,953
$
( 127 )
$
( 4,479 )
$
51,372
Issuance of common stock under employee stock option plans
398,084
—
1,473
—
—
1,473
Issuance of common stock pursuant to an At-the-Market offering, net of offering costs of $ 389
133,000
—
153
—
—
153
Stock-based compensation expense
—
—
1,496
—
—
1,496
Net loss
—
—
—
—
( 9,165 )
( 9,165 )
Net unrealized gain on available-for-sale investments
—
—
—
36
—
36
Balance, September 30, 2023
25,216,143
$
25
$
59,075
$
( 91 )
$
( 13,644 )
$
45,365
Accumulated
Additional
Other
Total
Common Stock
Paid-in
Comprehensive
Retained
Stockholders'
Shares
Amount
Capital
Loss
Earnings
Equity
Six months ended September 30, 2022
(In thousands, except share amounts)
Balance, March 31, 2022
24,486,239
$
24
$
53,083
$
( 154 )
$
11,498
$
64,451
Issuance of common stock under employee stock option plans
67,514
1
178
—
—
179
Stock-based compensation expense
—
—
1,299
—
—
1,299
Net loss
—
—
—
—
( 7,204 )
( 7,204 )
Net unrealized loss on available-for-sale investments
—
—
—
( 25 )
—
( 25 )
Balance, September 30, 2022
24,553,753
$
25
$
54,560
$
( 179 )
$
4,294
$
58,700
The accompanying notes are an integral part of these condensed consolidated financial statements.
5
Table of Contents
GSI TECHNOLOGY, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW S
(Unaudited)
Six Months Ended September 30,
2023
2022
(In thousands)
Cash flows from operating activities:
Net loss
$
( 9,165 )
$
( 7,204 )
Adjustments to reconcile net loss to net cash used in operating activities:
Allowance for credit losses
( 12 )
( 10 )
Provision for excess and obsolete inventories
94
89
Non-cash lease expense
290
281
Change in fair value of contingent consideration
( 324 )
( 830 )
Depreciation and amortization
505
510
Stock-based compensation
1,496
1,299
Amortization of premium on investments
( 2 )
12
Changes in assets and liabilities:
Accounts receivable
399
( 291 )
Inventories
744
( 966 )
Prepaid expenses and other assets
164
( 81 )
Accounts payable
( 159 )
205
Accrued expenses and other liabilities
( 325 )
( 1,387 )
Net cash used in operating activities
( 6,295 )
( 8,373 )
Cash flows from investing activities:
Maturities of short-term investments
2,750
4,250
Purchases of property and equipment
( 624 )
( 224 )
Net cash provided by investing activities
2,126
4,026
Cash flows from financing activities:
Proceeds from issuance of common stock under At-the-Market offering, net of offering costs of $ 389
153
—
Proceeds from issuance of common stock under employee stock plans
1,473
179
Net cash provided by financing activities
1,626
179
Net decrease in cash and cash equivalents
( 2,543 )
( 4,168 )
Cash and cash equivalents at beginning of the period
27,212
36,971
Cash and cash equivalents at end of the period
$
24,669
$
32,803
Non-cash investing and financing activities:
Operating lease right-of-use assets exchanged for lease obligations
$
637
$
376
Supplemental cash flow information:
Net cash paid for income taxes
$
61
$
82
The accompanying notes are an integral part of these condensed consolidated financial statements.
6
Table of Contents
GSI TECHNOLOGY, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1—THE COMPANY AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of presentation
The accompanying unaudited condensed consolidated financial statements of GSI Technology, Inc. and its subsidiaries (“GSI” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities and Exchange Commission. Accordingly, the interim financial statements do not include all of the information and footnotes required by GAAP for annual financial statements. These interim financial statements contain all adjustments (which consist of only normal, recurring adjustments) that are, in the opinion of management, necessary to state fairly the interim financial information included therein. The Company believes that the disclosures are adequate to make the information not misleading. However, these financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.
The consolidated results of operations for the six months ended September 30, 2023 are not necessarily indicative of the results to be expected for the entire fiscal year.
Reclassifications
Certain amounts in the fiscal 2022 condensed consolidated financial statements have been reclassified to conform to the fiscal 2023 presentation.
Significant accounting policies
There have been no material changes to our significant accounting policies that were disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.
Government Agreements
From time to time, the Company may enter into agreements with federal government agencies. GAAP does not have specific accounting standards covering agreements between the government and business entities. The Company applies International Accounting Standards 20 (“IAS 20”), Accounting for Government Grants and Disclosure of Government Assistance, by analogy when accounting for agreements entered into with the government. Under IAS 20, government grants or awards are initially recognized when there is reasonable assurance the conditions of the grant or award will be met and the grant or award will be received. After initial recognition, government grants or awards are recognized on a systematic basis in a manner consistent with the manner in which the Company recognizes the underlying costs for which the grant or award is intended to compensate. The Company follows ASC 832, Disclosures by Business Entities about Government Assistance, with respect to the disclosures of government grants or awards.
.
Credit Losses — Marketable Securities
For marketable securities in an unrealized loss position, the Company periodically assesses its portfolio for impairment. The assessment first considers the intent or requirement to sell the marketable security. If either of these criteria are met, the amortized cost basis is written down to fair value through earnings.
7
Table of Contents
Beginning April 1, 2023, if the criteria above are not met, the Company evaluates whether the decline resulted from credit losses or other factors by considering the extent to which fair value is less than amortized cost, any changes to the rating of the marketable security by a rating agency, and any adverse conditions specifically related to the marketable security, among other factors. If this assessment indicates that a credit loss exists, the present value of cash flows expected to be collected from the marketable security is compared to the amortized cost basis of the marketable security. If the present value of cash flows expected to be collected is less than the amortized cost basis, a credit loss exists and an allowance for credit losses is recorded, limited by the amount that the fair value is less than the amortized cost basis. Any other impairment that has not been recorded through an allowance for credit losses is recognized in other comprehensive loss.
Credit Losses — Accounts Receivable
Accounts receivable are recorded at the amounts billed less estimated allowances for credit losses for any potential uncollectible amounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from a customer’s inability to make required payments. The Company considers factors such as historical experience, credit quality, age of the accounts receivable balances, and economic conditions that may affect a customer’s ability to pay. Accounts receivable are written-off and charged against an allowance for credit losses when the Company has exhausted collection efforts without success.
Risk and uncertainties
The decline in the global economic environment due to, among other things, rising interest rates, worldwide inflationary pressures and significant fluctuations in energy prices has affected the business activities of the Company, its customers, suppliers, and other business partners in the fiscal year ended March 31, 2023 and into the six months ended September 30, 2023.
Our software development and certain regional sales activities for our APU product offerings occur in Israel. Our Vice President, Associative Computing, along with a team of software development experts are based in our Israel facility. This team is needed for the development of the various levels of software required in the use of our APU product offering. Proof of concept customers for our SAR imagine processing acceleration system are also based in Israel. We are closely monitoring developments in the evolving military conflict with Hamas that began on October 7, 2023 including potential impacts to our business, customers, employees and operations in Israel. At this time, the impact on GSI Technology are uncertain and subject to change given the volatile nature of the situation, but adverse changes in the military conditions in Israel could harm our business and our stock price could decline.
The Company believes that during the next 12 months disruptions in the capital markets as a result of rising interest rates, worldwide inflationary pressures, significant fluctuations in energy prices and the decline in the global economic environment could impact general economic activity and demand in the Company’s end markets. Additionally, fluctuations in customer demand due to previous buffer stock purchases during the semiconductor supply shortage may negatively impact near-term revenues.
Accounting pronouncements effective for fiscal 2024
In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 replaces the incurred loss impairment methodology in current GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For trade and other receivables, loans, and other financial instruments, the Company will be required to use a forward-looking expected loss model rather than the incurred loss model for recognizing credit losses which reflects losses that are probable. Credit losses relating to available-for-sale debt securities will also be recorded through an allowance for credit losses rather than as a reduction in the amortized cost basis of the securities. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. Application of the amendments is through a cumulative-effect adjustment to retained earnings as of the effective date. Adoption of this standard on April 1, 2023 did not have a material impact on the Company’s consolidated financial statements and related disclosures.
8
Table of Contents
NOTE 2—REVENUE RECOGNITION
The Company determines revenue recognition through the following steps: (1) identification of the contract with a customer; (2) identification of the performance obligations in the contract; (3) determination of the transaction price; (4) allocation of the transaction price to the performance obligations in the contract; and (5) recognition of revenue when, or as, we satisfy a performance obligation.
The Company’s customer contracts, which may be in the form of purchase orders, contracts or purchase agreements, contain performance obligations for delivery of agreed upon products. Delivery of all performance obligations contained within a contract with a customer typically occurs at the same time (or within the same accounting period). Transfer of control occurs at the point at which delivery has occurred, title and the risks and rewards of ownership have passed to the customer, and the Company has a right to payment. The Company recognizes revenue upon shipment of the product.
Because all of the Company’s performance obligations relate to contracts with a duration of less than one year, the Company has elected to apply the optional exemption practical expedient and, therefore, is not required to disclose the aggregate amount of the transaction price allocated to performance obligations that are unsatisfied or partially unsatisfied at the end of the reporting period.
The Company adjusts the transaction price for variable consideration. Variable consideration is not typically significant and primarily results from stock rotation rights and quick pay discounts provided to certain distributors. As a practical expedient, the Company is recognizing the incremental costs of obtaining a contract, specifically commission expenses that have a period of benefit of less than twelve months, as an expense when incurred. Additionally, the Company has adopted an accounting policy to recognize shipping costs that occur after control transfers to the customer as a fulfillment activity.
The Company’s contracts with customers do not typically include extended payment terms. Payment terms vary by contract type and type of customer and generally range from 30 to 60 days from shipment. Additionally, the Company has right to payment upon shipment.
The Company records revenue net of sales tax, value added tax, excise tax and other taxes collected concurrent with product sales. The impact of such taxes on products sales is immaterial.
The Company warrants its products to be free of defects generally for a period of three years . The Company estimates its warranty costs based on historical warranty claim experience and includes such costs in cost of revenues. Warranty costs and the accrued warranty liability were not material as of September 30, 2023 and March 31, 2023.
Substantially all of the Company’s revenue is derived from sales of SRAM products, which represent approximately 98 % and 96 % of total revenues in the six months ended September 30, 2023 and 2022, respectively.
Nokia, the Company’s largest customer, purchases products directly from the Company and through contract manufacturers and distributors. Based on information provided to the Company by its contract manufacturers and distributors, purchases by Nokia represented approximately 20 % and 14 % of the Company’s net revenues in the three months ended September 30, 2023 and 2022, respectively, and 27 % and 14 % of the Company’s net revenues in the six months ended September 30, 2023 and 2022, respectively.
See “Note 12 — Segment and Geographic Information” for revenue by shipment destination.
9
Table of Contents
The following table presents the Company’s revenue disaggregated by customer type.
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
Contract manufacturers
$
1,324
$
1,671
$
3,274
$
3,206
Distribution
4,356
6,813
7,970
14,118
OEMs
28
469
51
538
$
5,708
$
8,953
$
11,295
$
17,862
NOTE 3—NET LOSS PER COMMON SHARE
The Company uses the treasury stock method to calculate the weighted average shares used in computing diluted net loss per share. The following table sets forth the computation of basic and diluted net loss per share:
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands, except per share amounts)
(In thousands, except per share amounts)
Net loss
$
( 4,055 )
$
( 3,228 )
$
( 9,165 )
$
( 7,204 )
Denominators:
Weighted average shares—Basic
25,161
24,554
25,014
24,538
Dilutive effect of employee stock options
—
—
—
—
Dilutive effect of employee stock purchase plan options
—
—
—
—
Weighted average shares—Dilutive
25,161
24,554
25,014
24,538
Net loss per common share—Basic
$
( 0.16 )
$
( 0.13 )
$
( 0.37 )
$
( 0.29 )
Net loss per common share—Diluted
$
( 0.16 )
$
( 0.13 )
$
( 0.37 )
$
( 0.29 )
The following shares of common stock underlying outstanding stock options and unissued ESPP shares, determined on a weighted average basis, were excluded from the computation of diluted net loss per share as they had an anti-dilutive effect:
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
Shares underlying options and ESPP shares
7,854
8,277
7,862
8,204
NOTE 4—BALANCE SHEET DETAIL
September 30, 2023
March 31, 2023
(In thousands)
Inventories:
Work-in-progress
$
3,279
$
3,629
Finished goods
2,289
2,767
Inventory at distributors
9
19
$
5,577
$
6,415
10
Table of Contents
September 30, 2023
March 31, 2023
(In thousands)
Accounts receivable, net:
Accounts receivable
$
3,132
$
3,531
Less: Allowances for credit losses
( 48 )
( 60 )
$
3,084
$
3,471
September 30, 2023
March 31, 2023
(In thousands)
Prepaid expenses and other current assets:
Prepaid tooling and masks
$
210
$
333
Other receivables
168
156
Other prepaid expenses and other current assets
880
925
$
1,258
$
1,414
September 30, 2023
March 31, 2023
(In thousands)
Property and equipment, net:
Computer and other equipment
$
18,842
$
19,188
Software
4,428
4,428
Land
3,900
3,900
Building and building improvements
3,741
3,741
Furniture and fixtures
102
102
Leasehold improvements
918
910
31,931
32,269
Less: Accumulated depreciation
( 24,871 )
( 24,846 )
$
7,060
$
7,423
Depreciation expense was $ 172,000 and $ 196,000 for the three months ended September 30, 2023 and 2022, respectively, and $ 388,000 and $ 393,000 for the six months ended September 30, 2023 and 2022, respectively.
The following tables summarize the components of intangible assets and related accumulated amortization balances at September 30, 2023 and March 31, 2023 (in thousands):
As of September 30, 2023
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Intangible assets:
Product designs
$
590
$
( 590 )
$
—
Patents
4,220
( 2,548 )
1,672
Software
80
( 80 )
—
Total
$
4,890
$
( 3,218 )
$
1,672
As of March 31, 2023
Gross
Carrying
Amount
Accumulated
Amortization
Net Carrying
Amount
Intangible assets:
Product designs
$
590
$
( 590 )
$
—
Patents
4,220
( 2,430 )
1,790
Software
80
( 80 )
—
Total
$
4,890
$
( 3,100 )
$
1,790
11
Table of Contents
Amortization of intangible assets included in cost of revenues was $ 58,000 and $ 59,000 for the three months ended September 30, 2023 and 2022, respectively, and $ 117,000 for each of the six months ended September 30, 2023 and 2022.
The Company reviews identifiable amortizable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying value of the assets may not be recoverable. Determination of recoverability is based on the lowest level of identifiable estimated undiscounted cash flows resulting from use of the asset and its eventual disposition. Measurement of any impairment loss is based on the excess of the carrying value of the asset over its fair value. The Company identified a potential impairment indicator for the finite lived intangible assets and performed a recoverability test by comparing the sum of the estimated undiscounted future cash flows of the asset group to the carrying amount as of March 31, 2023. The result of the recoverability test indicated that the sum of the expected future cash flows was greater than the carrying amount of the finite lived intangible assets. Based on the uncertainty of forecasts inherent with a new product, events such as the failure to generate forecasted revenue from the APU product could result in a non-cash impairment charge in future periods.
As of September 30, 2023, the estimated future amortization expense of intangible assets in the table above is as follows (in thousands):
Fiscal year ending March 31,
2024 (remaining six months)
$
117
2025
233
2026
233
2027
233
2028
233
Thereafter
623
Total
$
1,672
September 30, 2023
March 31, 2023
(In thousands)
Accrued expenses and other liabilities:
Accrued compensation
$
3,320
$
3,441
Accrued commissions
200
214
Income taxes payable
343
345
Outsourced design resources
598
552
Miscellaneous accrued expenses
681
616
$
5,142
$
5,168
On November 30, 2022, the Company announced cost reduction initiatives which included an approximate 15 % reduction in the Company’s global workforce. The Company incurred $ 0.3 million in severance related charges during fiscal 2023 including $ 0.1 million recorded as cost of revenues and $ 0.2 million recorded as selling, general and administrative expenses. There were no severance related charges in the three and six months ended September 30, 2023 and 2022.
NOTE 5—GOODWILL
Goodwill represents the difference between the purchase price and the estimated fair value of the identifiable assets acquired and liabilities assumed in a business combination. The Company tests for goodwill impairment on an annual basis, or more frequently if events or changes in circumstances indicate that the asset is more likely than not impaired. The Company assesses goodwill for impairment on an annual basis on the last day of February in the fourth quarter of its fiscal year. The Company has one reporting unit.
The Company had a goodwill balance of $ 8.0 million as of both September 30, 2023 and March 31, 2023. The goodwill resulted from the acquisition of MikaMonu Group Ltd. in fiscal 2016.
12
Table of Contents
The Company completed its annual impairment test during the fourth quarter of fiscal 2023 and concluded that there was no impairment, as the fair value of its sole reporting unit exceeded its carrying value.
NOTE 6—INCOME TAXES
The current portion and long-term portion of the Company’s income tax liability related to unrecognized tax benefits was $ 0 at both September 30, 2023 and March 31, 2023. Due to historical losses in the United States, the Company has a full valuation allowance on its United States federal and state deferred tax assets. Management continues to evaluate the realizability of deferred tax assets and the related valuation allowance.
Management believes that within the next twelve months the Company will not have a significant reduction in uncertain tax benefits, including interest and penalties, related to positions taken with respect to credits and loss carryforwards on previously filed tax returns.
The Company’s policy is to include interest and penalties related to unrecognized tax benefits within the provision for income taxes in the Condensed Consolidated Statements of Operations.
The Company is subject to taxation in the United States and various state and foreign jurisdictions. Fiscal years 2013 through 2022 remain open to examination by federal tax authorities, and fiscal years 2012 through 2022 remain open to examination by California tax authorities. Fiscal years 2020, 2021, 2022 and 2023 are subject to audit by the Israeli tax authorities.
For the six months ended September 30, 2023 and September 30, 2022, the Company incurred income tax expense of $ 84,000 and $ 97,000 on net losses before income taxes of ($ 9.1 million) and ($ 7.1 million), respectively. The provision was calculated using the annualized effective tax rate method. The Company’s estimated annual effective income tax rate, including discrete items, was approximately ( 1.53 %) and ( 1.69 %) as of September 30, 2023 and 2022, respectively. The annual effective tax rates as of September 30, 2023 and 2022 vary from the United States statutory income tax rate primarily due to valuation allowances in the United States, whereby pre-tax losses do not result in the recognition of corresponding income tax benefits or foreign tax differential.
NOTE 7—FINANCIAL INSTRUMENTS
Fair value measurements
Authoritative accounting guidance for fair value measurements provides a framework for measuring fair value and related disclosures. The guidance applies to all financial assets and financial liabilities that are measured on a recurring basis. The guidance requires fair value measurement to be classified and disclosed in one of the following three categories:
Level 1: Valuations based on quoted prices in active markets for identical assets and liabilities. The fair value of available-for-sale securities included in the Level 1 category is based on quoted prices that are readily and regularly available in an active market. As of September 30, 2023, the Level 1 category included money market funds of $ 10.8 million, which were included in cash and cash equivalents on the Condensed Consolidated Balance Sheets.
Level 2: Valuations based on observable inputs (other than Level 1 prices), such as quoted prices for similar assets at the measurement date; quoted prices in markets that are not active; or other inputs that are observable, either directly or indirectly. The fair value of available-for-sale securities included in the Level 2 category is based on the market values obtained from an independent pricing service that were evaluated using pricing models that vary by asset class and may incorporate available trade, bid and other market information and price quotes from well-established independent pricing vendors and broker-dealers. As of September 30, 2023, the Level 2 category included short-term investments of $ 651,000 , which were comprised of government securities.
Level 3: Valuations based on inputs that are unobservable and involve management judgment and the reporting entity’s own assumptions about market participants and pricing. As of September 30, 2023, the
13
Table of Contents
Company’s Level 3 financial instruments measured at fair value on the Condensed Consolidated Balance Sheets consisted of the contingent consideration liability related to the acquisition of MikaMonu. The fair value of the contingent consideration liability was initially determined as of the acquisition date using unobservable inputs. These inputs included the estimated amount and timing of future cash flows, the probability achievement of the forecast and a risk-adjusted discount rate of approximately 14.8 % used to adjust the probability-weighted cash flows to their present value. Significant increases (decreases) to the estimated amount and timing of future cash flows or the probability of achievement of the forecast would result in a significantly higher (lower) fair value measurement. Conversely, a significant increase or (decrease) in the risk-adjusted discount rate would result in a significantly (lower) higher fair value measurement. Generally, changes used in the assumptions for future cash flows and probability of achievement of the forecast would be accompanied by a directionally similar change in the fair value measurement and expense. Conversely, changes in the risk-adjusted discount rate would be accompanied by a directionally opposite change in the related fair value measurement and expense. Subsequent to the acquisition date, at each reporting period, the contingent consideration liability is re-measured to fair value with changes recorded in selling, general and administrative expenses in the Condensed Consolidated Statements of Operations. During the most recent re-measurement of the contingent consideration liability as of September 30, 2023, the Company used a risk-adjusted discount rate of approximately 15.9 % to adjust the probability-weighted cash flows to their present value using probabilities ranging from 25 % to 70 % for the remaining contingent events. The contingent consideration liability is included in contingent consideration, non-current on the Condensed Consolidated Balance Sheets at September 30, 2023 and March 31, 2023 in the amount of $ 728,000 and $ 1.1 million, respectively.
The fair value of financial assets measured on a recurring basis is as follows (in thousands):
Fair Value Measurements at Reporting Date Using
Quoted Prices
in Active
Significant
Markets for
Other
Significant
Identical Assets
Observable
Unobservable
and Liabilities
Inputs
Inputs
September 30, 2023
(Level 1)
(Level 2)
(Level 3)
Assets:
Money market funds
$
10,778
$
10,778
$
—
$
—
Marketable securities
651
—
651
—
Total
$
11,429
$
10,778
$
651
$
—
Liabilities:
Contingent consideration
$
728
$
—
$
—
$
728
Fair Value Measurements at Reporting Date Using
Quoted Prices
in Active
Significant
Markets for
Other
Significant
Identical Assets
Observable
Unobservable
and Liabilities
Inputs
Inputs
March 31, 2023
(Level 1)
(Level 2)
(Level 3)
Assets:
Money market funds
$
7,796
$
7,796
$
—
$
—
Marketable securities
3,363
—
3,363
—
Total
$
11,159
$
7,796
$
3,363
$
—
Liabilities:
Contingent consideration
$
1,052
$
—
$
—
$
1,052
The following table sets forth the changes in fair value of contingent consideration for the six months ended September 30, 2023 and 2022, respectively:
14
Table of Contents
Six Months Ended September 30,
2023
2022
(In thousands)
Contingent consideration, beginning of period
$
1,052
$
2,738
Change due to accretion
70
102
Re-measurement of contingent consideration
( 394 )
( 932 )
Contingent consideration, end of period
$
728
$
1,908
Short-term investments
All of the Company’s short-term investments are classified as available-for-sale. Available-for-sale debt securities with maturities greater than twelve months are classified as long-term investments when they are not intended for use in current operations. Investments in available-for-sale securities are reported at fair value with unrecognized gains (losses), net of tax, as a component of accumulated other comprehensive loss in the Condensed Consolidated Balance Sheets. The Company had money market funds of $ 10.8 million and $ 7.8 million at September 30, 2023 and March 31, 2023, respectively, included in cash and cash equivalents on the Condensed Consolidated Balance Sheets. The Company monitors its investments for impairment periodically and records appropriate reductions in carrying values when declines are determined to be other-than-temporary.
The following table summarizes the Company’s available-for-sale investments:
September 30, 2023
Gross
Gross
Unrealized
Unrealized
Fair
Cost
Gains
Losses
Value
(In thousands)
Short-term investments:
Supranational obligations
$
655
$
—
$
( 4 )
$
651
Total short-term investments
$
655
$
—
$
( 4 )
$
651
March 31, 2023
Gross
Gross
Unrealized
Unrealized
Fair
Cost
Gains
Losses
Value
(In thousands)
Short-term investments:
Certificates of deposit
$
1,750
$
—
$
( 13 )
$
1,737
Supranational obligations
654
—
( 17 )
637
Agency bonds
999
—
( 10 )
989
Total short-term investments
$
3,403
$
—
$
( 40 )
$
3,363
The following table shows the gross unrealized losses and fair value of the Company’s investments with unrealized losses that do not have an allowance for credit losses, aggregated by investment category and length of time that individual securities have been in a continuous loss position as of September 30, 2023 and March 31, 2023, respectively.
September 30, 2023
Less Than 12 Months
12 Months or Greater
Total
Fair
Unrealized
Fair
Unrealized
Fair
Unrealized
Value
Loss
Value
Loss
Value
Loss
(In thousands)
Supranational obligations
$
—
$
—
$
651
$
( 4 )
$
651
$
( 4 )
$
—
$
—
$
651
$
( 4 )
$
651
$
( 4 )
15
Table of Contents
March 31, 2023
Less Than 12 Months
12 Months or Greater
Total
Fair
Unrealized
Fair
Unrealized
Fair
Unrealized
Value
Loss
Value
Loss
Value
Loss
(In thousands)
Certificates of deposit
$
—
$
—
$
1,737
$
( 13 )
$
1,737
$
( 13 )
Agency bonds
—
—
990
( 10 )
990
( 10 )
Supranational obligations
—
—
636
( 17 )
636
( 17 )
$
-
$
-
$
3,363
$
( 40 )
$
3,363
$
( 40 )
The Company’s investment portfolio consists of governmental securities that have a maximum maturity of three years . All unrealized gains and losses are due to changes in interest rates and bond yields. Subject to normal credit risks, the Company has the ability to realize the full value of all these investments upon maturity. All available-for-sale investment securities are either fully insured or contractual terms of the investment do not permit the issuer to settle the security at a price less than the amortized cost of the investment. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investment before recovery of the amortized cost basis.
The deferred tax asset related to unrecognized gains and losses on short-term investments was $ 1,000 and $ 10,000 at September 30, 2023 and March 31, 2023, respectively.
As of September 30, 2023, contractual maturities of the Company’s available-for-sale investments were as follows:
Fair
Cost
Value
(In thousands)
Maturing within one year
$
655
$
651
Maturing in one to three years
—
—
$
655
$
651
The Company classifies its short-term investments as “available-for-sale” as they are intended to be available for use in current operations.
NOTE 8—LEASES
The Company has operating leases for corporate offices and research and development facilities. The Company’s leases have remaining lease terms of 5 months to 43 months , some of which include options to extend for up to 5 years .
On June 29, 2023, the Company entered into a lease agreement in Taiwan, wherein the lease for the Company’s existing office and warehouse space was extended through August 31, 2026. The lease has been extended for a three-year period under substantially the same terms and conditions of the original lease agreement. The Company identified this extension as a lease modification and reassessed the discount rate at the remeasurement date, at 3.9 % based on local rates in Taiwan, and the Company has remeasured its ROU asset and lease liability on the condensed consolidated balance sheet using the discount rate that applies as of the date of the modification.
Supplemental balance sheet information related to leases was as follows:
As of
As of
September 30, 2023
March 31, 2023
(In thousands)
Operating Leases
Operating lease right-of-use assets
$
1,031
$
684
Lease liabilities-current
$
396
$
413
Lease liabilities-non-current
592
238
Total operating lease liabilities
$
988
$
651
16
Table of Contents
The following table provides the details of lease costs:
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
Operating lease cost
$
141
$
149
$
284
$
299
Short-term lease cost
8
8
16
16
$
149
$
157
$
300
$
315
The following table provides other information related to leases:
Six Months Ended September 30,
2023
2022
(In thousands)
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases
$
283
$
298
Right-of-use assets obtained in exchange for lease obligations
Operating leases
$
637
$
376
Weighted-average remaining lease term (years):
Operating leases
2.85
2.57
Weighted-average discount rate:
Operating leases
4.11 %
4.35 %
The following table provides the maturities of the Company’s operating lease liabilities as of September 30, 2023:
Operating Lease
Liabilities
Fiscal Year
(In thousands)
2024 (remaining six months)
$
251
2025
303
2026
305
2027
180
2028
7
Total undiscounted future cash flows
1,046
Less: Imputed interest
( 58 )
Present value of undiscounted future cash flows
$
988
Presentation on statement of financial position
Current
$
396
Non-current
$
592
NOTE 9—COMMITMENTS AND CONTINGENCIES
Indemnification obligations
The Company is a party to a variety of agreements pursuant to which it may be obligated to indemnify the other party with respect to certain matters. Typically, these obligations arise in the context of contracts entered into by the Company, under which the Company agrees to hold the other party harmless against losses arising from a breach of representations and covenants related to such matters as title to assets sold and certain intellectual property
17
Table of Contents
rights. In each of these circumstances, payment by the Company is conditioned on the other party making a claim pursuant to the procedures specified in the particular contract, which procedures typically allow the Company to challenge the other party’s claims. Further, the Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by it under these agreements.
It is not possible to predict the maximum potential amount of future payments that may be required under these or similar agreements due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under these agreements have not had a material effect on its business, financial condition, cash flows or results of operations.
NOTE 10—STOCK-BASED COMPENSATION
As of September 30, 2023, 3,076,860 shares of common stock were available for grant under the Company’s Amended and Restated 2016 Equity Incentive Plan.
The following table summarizes the Company’s stock option activities for the six months ended September 30, 2023:
Weighted
Number of Shares
Average
Weighted
Shares
Underlying
Remaining
Average
Available for
Options
Contractual
Exercise
Intrinsic
Grant
Outstanding
Life (Years)
Price
Value
Balance at March 31, 2023
3,594,851
8,809,160
$
5.62
Granted
( 639,053 )
639,053
$
4.55
Exercised
—
( 235,888 )
$
5.13
$
313,926
Forfeited
121,062
( 580,193 )
$
6.23
Balance at September 30, 2023
3,076,860
8,632,132
5.77
$
5.51
Options vested and exercisable
5,495,970
4.21
$
6.04
$
148,839
Options vested and expected to vest
8,531,774
5.75
$
5.53
$
431,582
The following table summarizes stock-based compensation expense by line item in the Condensed Consolidated Statements of Operations, all relating to employee stock plans:
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
Cost of revenues
$
57
$
49
$
124
$
109
Research and development
369
390
755
741
Selling, general and administrative
250
222
617
449
Total
$
676
$
661
$
1,496
$
1,299
NOTE 11—RELATED PARTY TRANSACTION
The Company incurred non-recurring engineering service expense and production charges of approximately $ 0 and $ 140,000 during the three months ended September 30, 2023 and 2022, respectively, and $ 0 and $ 197,000 during the six months ended September 30, 2023 and 2022, respectively, from Wistron Neweb Corp (“WNC”) in connection with the manufacturing of single-APU PCIe boards, to be used in the Company’s in-place associative computing product. Haydn Hsieh, a member of the Company’s board of directors, is the Chairman and Chief Strategy Officer of WNC. The amount owed to WNC, of $ 0 and $ 8,000 at September 30, 2023 and March 31, 2023, respectively, is included in accounts payable in the Condensed Consolidated Balance Sheets.
NOTE 12—SEGMENT AND GEOGRAPHIC INFORMATION
Based on its operating management and financial reporting structure, the Company has determined that it has one reportable business segment: the design, development and sale of integrated circuits.
18
Table of Contents
The following is a summary of net revenues by geographic area based on the location to which product is shipped:
Three Months Ended September 30,
Six Months Ended September 30,
2023
2022
2023
2022
(In thousands)
(In thousands)
United States
$
2,948
$
5,034
$
6,035
$
8,601
China
312
310
481
1,198
Singapore
459
1,561
952
3,510
Netherlands
939
785
1,955
1,457
Germany
867
1,015
1,550
2,452
Rest of the world
183
248
322
644
$
5,708
$
8,953
$
11,295
$
17,862
All sales are denominated in United States dollars.
NOTE 13—GOVERNMENT AGREEMENTS
In June 2023, the Company entered into a prototype agreement with the Space Development Agency for the development of a Next-Generation Associative Processing Unit-2 for Enhanced Space-Based Capabilities (“Prototype Agreement”). Under the Prototype Agreement, the Company will receive an award funded by the Small Business Innovation Research program. Pursuant to an agreed-upon schedule, the Company will receive milestone payments totaling an estimated $ 1.25 million upon successful completion of each milestone. The Prototype Agreement is unrelated to the Company’s ordinary business activities. The Company has discretion in managing the activities under the Prototype Agreement and retains all developed intellectual property. The Company applies IAS 20, by analogy, and recognizes the award as a reduction of research and development expenses based on a cost incurred method.
During the three and six months ended September 30, 2023, the Company recognized $ 260,000 as a reduction to research and development expense in the Condensed Consolidated Statements of Operations. As of September 30, 2023, the Company had received total milestone payments of $ 297,000 under the Prototype Agreement.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.